Protease-activated receptors as drug targets in inflammation and pain
- 1 September 2009
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 123 (3) , 292-309
Abstract
No abstract availableKeywords
This publication has 144 references indexed in Scilit:
- Proteinases and signalling: pathophysiological and therapeutic implications via PARs and moreBritish Journal of Pharmacology, 2008
- 'Role reversal' for the receptor PAR1 in sepsis-induced vascular damageNature Immunology, 2007
- Protease-Activated Receptor 2, Dipeptidyl Peptidase I, and Proteases Mediate Clostridium difficile Toxin A EnteritisGastroenterology, 2007
- Mechanisms of protease‐activated receptor 2‐evoked hyperexcitability of nociceptive neurons innervating the mouse colonThe Journal of Physiology, 2007
- Protease‐activated receptor‐4: a novel mechanism of inflammatory pain modulationBritish Journal of Pharmacology, 2007
- Protease‐activated receptor 2 sensitizes the transient receptor potential vanilloid 4 ion channel to cause mechanical hyperalgesia in miceThe Journal of Physiology, 2007
- Serratia marcescensSerralysin Induces Inflammatory Responses through Protease-Activated Receptor 2Infection and Immunity, 2007
- Protease‐activated receptor 2 sensitizes TRPV1 by protein kinase Cɛ‐ and A‐dependent mechanisms in rats and miceThe Journal of Physiology, 2006
- Up-regulation of protease-activated receptor-2 by bFGF in cultured human synovial fibroblastsLife Sciences, 2006
- Thrombin Attenuates Neuronal Cell Death and Modulates Astrocyte Reactivity Induced by β‐Amyloid In VitroJournal of Neurochemistry, 1996